BIO
Bio-Rad Laboratories Inc
379.60$
+0.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.2% | +2.4% | +4.4% | +6.0% | +0.9% | +10.1% | +14.8% | -4.1% | -4.7% | -3.9% | +0.7% | |
| – | -9.9% | +3.6% | +4.6% | +9.6% | -1.0% | +5.0% | +16.0% | -3.9% | +0.8% | -4.6% | +4.4% | |
| – | -4.8% | +1.5% | +4.3% | +3.1% | +2.7% | +14.4% | +13.9% | -4.3% | -9.0% | -3.4% | -2.6% | |
| – | -12.4% | +6.7% | +21.6% | -20.4% | +1.8% | +7.4% | +19.7% | -1.4% | -3.7% | +19.6% | -13.2% | |
| – | -5.7% | +7.2% | -1.0% | +3.2% | -1.2% | -3.0% | +9.9% | -5.9% | +2.3% | -3.9% | +3.7% | |
| – | -7.2% | +7.1% | +3.6% | -2.5% | -0.5% | -1.0% | +11.9% | -4.7% | +0.4% | +1.9% | -2.9% | |
| – | +11.2% | -68.1% | +119.3% | -193.1% | – | +83.5% | +18.8% | -3.5% | -30.0% | -20.4% | +0.6% | |
| – | -2.0% | +7.8% | -1.6% | +4.1% | -2.3% | -6.6% | -92.9% | +2,357.4% | +29.7% | -1.1% | +0.2% | |
| – | +10.9% | -71.5% | +135.3% | +418.7% | +345.7% | +117.5% | +10.8% | -186.3% | – | – | – | |
| – | -23.3% | -59.0% | -226.1% | – | +243.3% | +119.7% | +8.2% | -190.1% | – | – | – | |
| – | +27.3% | -75.1% | +308.0% | +214.6% | +387.2% | +116.9% | +11.5% | -185.3% | – | – | – | |
| – | -1.4% | -31.0% | +30.6% | +150.3% | +264.4% | +106.5% | +10.0% | -180.3% | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.